Abstract
We have synthesized a series of polymethoxylated rigid analogs of combretastatin A-4 which contain a benzoxepin ring in place of the usual ethylene bridge present in the natural combretastatin products. The compounds display antiproliferative activity when evaluated against the MCF-7 and MDA human breast carcinoma cell lines. 5-(3-Hydroxy-4-methoxyphenyl)-4-(3,4,5- trimethoxyphenyl)-2,3-dihydro-benzoxepine (11g) was found to be the most potent product when evaluated against the MCF-7 breast cancer cell line. A brief computational study of the structureactivity relationship for the synthesized compounds is presented. These 4,5-diarylbenzoxepins are identified as potentially useful scaffolds for the further development of antitumor agents which target tubulin. © 2010 Informa UK Ltd.
Author supplied keywords
Cite
CITATION STYLE
Barrett, I., Carr, M., O’Boyle, N., Greene, L. M., J. S. Knox, A., Lloyd, D. G., … Meegan, M. J. (2010). Lead identification of conformationally restricted benzoxepin type combretastatin analogs: Synthesis, antiproliferative activity, and tubulin effects. In Journal of Enzyme Inhibition and Medicinal Chemistry (Vol. 25, pp. 180–194). https://doi.org/10.3109/14756360903169659
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.